Latest Breaking News On - Reexamination during - Page 1 : comparemela.com

10X Genomics challenged claims in Bio-Rad’s U.S. Pat. No. 9,562,837 and 9,896,722. The PTAB issued four mixed Final Written Decisions in 10X Genomics Inc. v. Bio-Rad Labs., Inc., IPR2020-00086, -00087, -00088, and -00089, finding most claims unpatentable but allowing a few to survive.

Bio rad us patAndrew failePatent public advisory committee quarterly meeting0x genomics incBio rad labs incFinal written decisionsRad labsPatent ownerRegarding optionsPatent owner through reissueReexamination duringPatent ownersFinal written decisionPendency updateContinuation practice dataDeputy commissioner